Search
Now showing items 1-10 of 21
Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies.
(Wiley Online Library., 2014)
Abstract available in pdf.
Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial.
(Succop, S.M., MacQueen, K.M., van Loggerenberg, F., Majola, N., Abdool Karim, Q. and Abdool Karim, S.S. 2014. Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial. AIDS care 26(12), 1521-1525., 2014)
Abstract available in pdf.
ARV-based HIV prevention for women Á where are we in 2014.
(International AIDS Society., 2014)
Abstract available in pdf.
Antibodies for HIV prevention in young women.
(Wolters Kluwer., 2015)
Abstract available.
Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
(International AIDS Society., 2015)
Abstract available in pdf.
Low adverse event rates following voluntary medical male circumcision in a high HIV disease burden public sector prevention programme in South Africa.
(International AIDS Society., 2014)
Introduction: The provision of voluntary medical male circumcision (VMMC) services was piloted in three public sector facilities in a high HIV disease burden, low circumcision rate province in South Africa to inform policy ...
Factors associated with the take-up of voluntary medical male circumcision amongst learners in rural KwaZulu-Natal.
(National Inquiry Services Centre., 2017)
Abstract available in pdf.
Adherence in the CAPRISA 004 tenofovir gel microbicide trial.
(Springer., 2014)
High adherence is key to microbicide effectiveness. Here we provide a description of adherence
interventions and the adherence rates achieved in the CAPRISA 004 Tenofovir Gel Trial.
Adherence support for the before-and-after ...
Assessing adherence in the CAPRISA 004 tenofovir gel HIV prevention trial: results of a nested case–control study.
(Springer., 2014)
Abstract available in pdf.
Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial.
(Oxford University Press., 2014)
The Centre for the AIDS Programme of Research in South Africa 004 (CAPRISA 004) study demonstrated that vaginally applied tenofovir gel is a promising intervention for protecting women from sexually acquiring human ...